Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $10.69 Consensus PT from Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been given a consensus rating of “Hold” by the eleven research firms that are covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $10.6875.

AVAH has been the topic of a number of recent analyst reports. Truist Financial raised their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. Raymond James Financial reissued an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a research note on Friday, December 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. Finally, Royal Bank Of Canada boosted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 10,000,000 shares of the stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total value of $90,000,000.00. Following the completion of the sale, the insider directly owned 386,284 shares in the company, valued at $3,476,556. This represents a 96.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of Aveanna Healthcare stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $90,000,000.00. Following the transaction, the insider owned 386,284 shares in the company, valued at $3,476,556. This trade represents a 96.28% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 32,597,968 shares of company stock valued at $293,381,712. Company insiders own 7.80% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

Several large investors have recently made changes to their positions in the stock. Banque Transatlantique SA acquired a new position in Aveanna Healthcare in the 1st quarter worth $25,000. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $43,000. Diversified Trust Co bought a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $57,000. Jump Financial LLC acquired a new position in Aveanna Healthcare during the 1st quarter worth approximately $59,000. Finally, MQS Management LLC bought a new position in shares of Aveanna Healthcare during the 2nd quarter worth approximately $59,000. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Price Performance

Shares of AVAH stock opened at $8.62 on Wednesday. The firm’s 50 day moving average price is $9.07 and its two-hundred day moving average price is $7.38. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare has a 52-week low of $3.67 and a 52-week high of $10.32. The stock has a market cap of $1.80 billion, a PE ratio of 23.94 and a beta of 2.04.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The company had revenue of $450.53 million for the quarter. As a group, analysts forecast that Aveanna Healthcare will post -0.06 EPS for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.